Klein Lawrence Otto
SEC insider (Form 3/4/5 filer). CIK 0001762583. Chief Executive Officer at Oruka Therapeutics, Inc. (ORKA) and 1 other issuer. 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in MENLO PARK, CA.
Companies Klein Lawrence Otto has filed insider reports for
- Oruka Therapeutics, Inc. (ORKA): Director, Officer, Chief Executive Officer
- Jade Biosciences, Inc. (JBIO): Director
Klein Lawrence Otto
CIK: 0001762583
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect200 shares at avg. $84.78$17K - Oct 1, 2026ORKA
Oruka Therapeutics, Inc.
ExerciseDirect25K shares at avg. $7.80$195K - Oct 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect16.2K shares at avg. $83.40$1.4M - Oct 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect8.6K shares at avg. $84.03$719K - Sep 15, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect2.5K shares at avg. $95.71$235K - Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect4.8K shares at avg. $92.44$444K - Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
ExerciseDirect75K shares at avg. $7.80$585K - Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect6.6K shares at avg. $90.79$600K - Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect63.6K shares at avg. $91.90$5.8M - Jun 15, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect1.7K shares at avg. $69.69$120K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  ORKA Oruka Therapeutics, Inc. | Sale | 200 | $84.78 | $16,956 | Direct |
| Oct 1, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise | 25,000 | $7.80 | $195,000 | Direct |
| Oct 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 16,246 | $83.40 | $1,354,882 | Direct |
| Oct 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 8,554 | $84.03 | $718,755 | Direct |
| Sep 15, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 2,452 | $95.71 | $234,681 | Direct |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 4,800 | $92.44 | $443,691 | Direct |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise | 75,000 | $7.80 | $585,000 | Direct |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 6,604 | $90.79 | $599,556 | Direct |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 63,596 | $91.90 | $5,844,237 | Direct |
| Jun 15, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 1,729 | $69.69 | $120,494 | Direct |
1-10 of 15 transactions